A Cell Press partner journal
See the unseen. Change the unchanged.
The Innovation ¡ª published by Cell Press in partnership with members of the Youth
Innovation Promotion Association (YIPA),a part of the Chinese Academy of
Sciences¡ªis a new broad-scope, open access journal publishing basic and applied
research that has impact for the benefit of society.
On the cover: Medicine is the practice of the diagnosis, treatment, and prevention of disease. With the advances in medical science, human beings are getting both longer life spans and higher quality of life. From herbs to molecular signatures, humankind is experiencing a transition from traditional medicine to personalized medicine: the right treatment to the right patient at the right time. However, it is not so easy to achieve this goal because the etiology of most diseases and disorders is still unclear. From description to association, numerous researchers are working together to decipher the mechanisms behind disease. To address such challenges, more and more global collaborations are badly needed to include experts from all disciplines: not just doctors, scientists and administration staff, but also engineers, technicians and marketing managers. Not limited to a fish-eye view, we humans should widen our vision and get more deep insights beyond the human community. That is the right way to assure sustainable healthcare for humanity.
  Related comments
Add comment (English only)
Name*:  
E-mail:  
Telephone:  
Code:    
Comments*:
Position: Home > issue > May 10, 2022 Volume 3, Issue 3
Why is the SARS-CoV-2 Omicron variant milder?
Category:   Commentary   Download:  PDF  Figure  Endnote
Author: Bingqing Xia, Yi Wang, Xiaoyan Pan, Xi Cheng, Hongying Ji, Xiaoli Zuo, Hualiang Jiang, Jia Li, Zhaobing Gao

b2.jpg

The single point mutation T9I in the envelope protein of the SARS-CoV-2 Omicron variant changes channel properties and attenuates virus production and virulence


In November 2021, a new SARS-CoV-2 variant emerged in South Africa and was designated the fifth variant of concern and named Omicron. It was detected in more than 26 countries worldwide, including China. The Omicron variant is highly transmissible and has extensive morbidity, which has raised concerns related to antiviral therapy. Recent reports have revealed that the Omicron variant exhibits a longer cycle of viral shedding and a decreased replication capacity and results in substantially attenuated lung pathology, indicating that the pathogenic ability of the Omicron variant is lower than that of previous variants.





Host
ISSN 2666-6758
Publishing partner
Journal links
 
Academic co-partner
SHANGHAI INSTITUTE OF APPLIED PHYSICS, CAS
INSTITUTE OF MICROBIOLOGY, CAS
XI'AN INSTITUTE OF OPTICS AND PRECISION MECHANICS, CAS
 
Collections

Air Pollution
Astronomy
Cancer
Chemistry & Materials
COVID-19
Environment Changes
Geoscience
Life Science & Medicine
Physics
ScienceX / Interdiscipline

 
Stay connected
  the.innovation.journal
  the.innovation.journal
  The Innovation
  TheInnovation´´ÐÂ
  TheInnovation´´ÐÂ
  The_Innovation
  office@the-innovation.org

Official£º@The_InnovationJ
Astronomy£º@TheInnovationA3
Chemistry£º@InnovationChem
Geoscience£º@TheInnovationG2
Informatics£º@Innovation_inf
Life Science£º@InnovationLS
Management£º@TheInnovationM1
Materials£º@TheInnovationM2
Medicine£º@Theinnovation_m
Physics£º@TheInnovationP1
ScienceX£º@TheInnovSciX

  Copyright © 2019-2022 Youth Innovation All Rights Reserved